Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Retatrutide is an investigational triple GLP-1/GIP/glucagon receptor agonist not approved by the MHRA or EMA
Standard shipping charges based on the product weight and shipping location shall be applicable to these products
The particular peptides that now reside on the FDAs Category 2 Bulk Substances list never met the criteria for compounding, yet some pharmacies had been supplying them anyway to patients with a physicians prescription
A little difficult to find but I am not from the area
This commitment to quality ensures that every compound we create meets the highest standards of purity, potency, and safety
US$ 28.35
US$ 23.30
US$ 25.90
US$ 25.30
US$ 24.29
